A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®

Overview

open label, active-controlled, randomized, parallel group, comparative study.

This is a phase III comparative study to evaluate the effectiveness and safety of DA-3801 in treatment of the patients with WHO Group II anovulatory infertility failing to clomiphene citrate treatment. The study is conducted with following methods: open label, active-controlled, randomized, parallel group, comparative.

Conditions

Interventions

Eligibility

Locations (1)

Outcomes